Moreover, the study has uncovered a previously unrecognized positive-feedback loop in the STAT3–TINCR–EGFR signaling axis in tumorigenesis, and this feedback loop could thus represent a new target in pharmacological strategies for treating human breast cancer. This evidence concerns the gene EGFR and breast cancer.